Arkolith/Insider Trading/NRIX/Form 4

Ring Christine

Chief Legal OfficerNurix Therapeutics, Inc. (NRIX) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$259K
Net Open-Market Flow
-$259K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)5K$1.86$10K19K
Jul 2, 2026Option exercise(M)6K$8.72$50K25K
Jul 2, 2026Sell(S)11K$23.56$259K14K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)5K—$00
Jul 2, 2026Option exercise(M)6K—$0129K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001817199-26-000024) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML